These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1162 related articles for article (PubMed ID: 16412159)
1. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study. Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159 [TBL] [Abstract][Full Text] [Related]
2. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg. Schreiber CP; Cady RK Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [TBL] [Abstract][Full Text] [Related]
7. Sumatriptan and naproxen sodium for the acute treatment of migraine. Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults. Winner P; Adelman J; Aurora S; Lener ME; Ames M Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Diener HC Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900 [TBL] [Abstract][Full Text] [Related]
10. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache. Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945 [TBL] [Abstract][Full Text] [Related]
11. Almotriptan improves response rates when treatment is within 1 hour of migraine onset. Dowson AJ; Massiou H; Lainez JM; Cabarrocas X Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355 [TBL] [Abstract][Full Text] [Related]
12. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Diener HC; Gendolla A; Gebert I; Beneke M Headache; 2005; 45(7):874-82. PubMed ID: 15985104 [TBL] [Abstract][Full Text] [Related]
13. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Winner P; Landy S; Richardson M; Ames M Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache. Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078 [TBL] [Abstract][Full Text] [Related]
15. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Sargent J; Kirchner JR; Davis R; Kirkhart B Neurology; 1995 Aug; 45(8 Suppl 7):S10-4. PubMed ID: 7644079 [TBL] [Abstract][Full Text] [Related]
16. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life. Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178 [TBL] [Abstract][Full Text] [Related]
17. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group. Tepper SJ; Cochran A; Hobbs S; Woessner M Int J Clin Pract; 1998; 52(1):31-5. PubMed ID: 9536565 [TBL] [Abstract][Full Text] [Related]
18. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Cutler N; Mushet GR; Davis R; Clements B; Whitcher L Neurology; 1995 Aug; 45(8 Suppl 7):S5-9. PubMed ID: 7644082 [TBL] [Abstract][Full Text] [Related]
19. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study). Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ; Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358 [TBL] [Abstract][Full Text] [Related]
20. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group. Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]